Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Planning for retirement at the right age is crucial for financial security. Discover how to choose the best age to start your retirement plan.
26,113 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
Investors eye Xcel Brands (XELB) 2026 as it reports Q1 results. This guide explains what to look for in the transcrip...
DraftKings fights for growth across shifting state rules and expanding iGaming. This article breaks down what to watc...
When a pop star's song is used in a political clip, it hits beyond headlines. This article breaks down the money move...
Regulators scrutinize exchange activity amid sanction challenges. This article breaks down CoinEx's denial, the fund ...
Former official presses lawmakers to reclassify online event markets, arguing they are sports betting. The move inten...
PayPal’s plunging stock drags down YieldMax’s PYPY, with weekly distributions shrinking as Q4 2025 missed expectation...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
A leading global shipping ETF is drawing attention for its current yield and rebound potential as sea lanes remain vo...
Gladstone Investment faces a quarterly miss that pressures its 5.7% yield, spotlighting the risks and resilience of a...
Defense technology is approaching a market shakeout as government procurement reforms accelerate purchases and ventur...